Introduction
Recent years analytical technology of proteomics has been significantly improved, and now proteomics becomes important methodology to discover biomarkers and target molecules in medical and pharmaceutical sciences. However comparing with genomics approach such as transcriptome analysis, there was a difficulty in quantification. Since this is a crucial point to explore biomarkers, several experimental methods for quantitative differential display are developed based on the labeling method like ICAT. From the viewpoint of biomarker discovery, extensive and unbiased exploratory method is essential, but such labeling might cause sampling bias or artificial errors.
Here, we developed a new quantitative proteomics data mining method free from any artificial experimental treatment.
Method and Results
Our analysis method accepts plural number of LC-MS data derived from more than one groups, and generates a list of proteins whose amount is significantly different between the groups. Here, groups might correspond to, for example, healthy vs. disease groups for the discovery of disease-related proteins, or treated vs. untreated patients for the analysis of drug efficacy, safety, mechanism, and so on.
The input LC-MS data is represented as a set of multi-dimensional values (V) consists of ( (a set of fraction numbers (F i ) of i-th separation chromatography), retention time of the last chromatography (T ), mass value (mass charge ratio M ), ion signal intensity (I)). After peak detection process, each value V can be expected to be derived from single molecular ion, where the last element I represent a quantified value relating to the amount of the molecular ion, and the rest parts (F i , T, M) describe the property of the ion. Ideally, a certain specific value of (F i , T, M) provides a unique molecular ion.
So we need to accumulate whole signal information for every (F i , T, M). To achieve the accumulation, we must be aware that these values fluctuate sample by sample, measurement by measurement. Especially it is well known that chromatography retention time varies non-linearly, and to overcome this problem, several methods like Dynamic Time Warping or Correlation Optimized Warping were developed [1] . These methods are based on the dynamic programming, however, they were originally developed for data processing of one dimensional chromatogram where intensity is represented along the time axis. Here we developed a new method to overlay two multi-dimensional profiles like MuD-LC-MS mass chromatograms. This method is based on the dynamic programming, but is not limited to a single value alignment on single property.
Another contrivance of our method is that we adopt several internal standard materials that are injected prior to measurement. These standard signals are not only used for normalization of signal intensity but also used as landmarks to adjust two profiles each other. This contrivance also improves the speed of alignment by reducing the search space, as well as serves to construct more accurate alignments.
We named this method as i-OPAL -internal standard guided Optimal Profile Alignment. Our i-OPAL method is applicable as an in silico differential display method to explore biomarkers that characterize certain diseases, symptoms, responses of treatments, adverse events by certain drugs and so on. That is, we can compare two LC-MS profiles derived from two different conditions by aligning tow profiles using i-OPAL. Furthermore, i-OPAL is also useful to accumulate plural number of profiles derived from plural number of samples. This process corresponds to sample mixing manipulation, but in silico mixing is much better because we can obtain variance information as well as total or average values. This means we can estimate to what extent the groups are homogeneous and how far differences of two groups are significant.
In order to show capability to mine quantitatively significantly changed signals, we firstly apply our program to artificial protein mixture. The artificial sample consists of 6 proteins. 5 have constant concentration and the rest one is variable. For example, in the case of the comparison of 500 fmol vs. 0 fmol of the last variable protein, we have mined 127 signal points out of about 15,000 total aligned signal points, screened by single-sided t test of significance level 0.5 % and other conditions concerning the minimum value of the signal intensity. Among the selected 127 points, 103 were confirmed to be the true targets.
We also applied our method to mine candidate marker proteins that are related to cancer metastasis using real clinical samples. We adopted inter-group comparison using tissue samples of 36 lung cancer patients who had either lymph node metastasis or not. Using t test screening and other filtering, finally we obtained 604 proteins list that are related to lung cancer metastasis. The list of course contains many proteins, like MTA3, Integrins, Laminins, EGF & EGFR, etc, that are already known to be related to metastasis or cancer.
Discussions
Quantitative proteomics have been considered rather difficult comparing with transcriptome analysis using microarrays. Our i-OPAL program will make it much easier to compare multiple states of proteome from plural number of samples by in silico differential display and in silico mixture functionality. It is recognized that proteomics approach is more suitable for pathology rather than genetics. Therefore we believe our i-OPAL method become quite useful tool to mine biomarkers and to elucidate disease and drug mechanisms.
